Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine hydrochloride after PCI in stable coronary artery disease
ChiCTR1900023731Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xinjiang Medical University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of berberine in coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoint: Major adverse cardiovascular events. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
berberine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1900023731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023731.